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Increasing breastfeeding rates and reducing HIV/AIDS are two important global health priorities,
and their intersection has led to policies that meet mutual goals of supporting, protecting and
promoting breastfeeding and reducing the risk of HIV/AIDS. The World Health Organization
has developed and released recommendations, policies, and guidance on infant feeding and the
risk of transmission through breastfeeding. This analysis provides a historical, chronological
perspective on the global policies for infant feeding in the case of an HIV-positive mother, an
analysis of changes, and recommendations for the future. The policies evaluated demonstrate the
evolution in knowledge and recommendations for infant feeding practices in the setting of HIV.
Over time, significant changes can be found in the policies regarding breastfeeding, mixed
feeding, antiretroviral use, and the inclusion of evidence. In the beginning, women with HIV
were advised not to breastfeed their infants, mixed feeding was not discussed, antiretrovirals had
not been developed, and citations of evidence were not included. With the latest policies,
breastfeeding was encouraged, mixed feeding was not advised due to evidence of an increased
risk of harm to the infant, and research was both cited and discussed in terms of quality and
strength. This evaluation of previous policies has demonstrated the need for continually
clarifying terminology, descriptive criteria and practices, and increasing the evidence-base in
order to create effective and accurate recommendations in the future.
Keywords: infant feeding, HIV/AIDS policy, HIV transmission
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Human Immunodeficiency Virus (HIV) is a significant global public health issue. Since
its discovery in 1981 (AIDS.gov, n.d.), it has caused more than 39 million deaths (World Health
Organization [WHO], 2014b). Despite significant advances in treatment and survivability, it
remains a global burden: in 2013, more than 2.1 million people were diagnosed with HIV
(WHO, 2014b). HIV is a virus that targets and weakens the immune system, making the people
infected more susceptible to infections and some cancers. Immune function is typically measured
by the number of cluster of differentiation four cells (CD4 cell count), one of the immune system
cells in the human body targeted by HIV (Centers for Disease Control and Prevention [CDC],
2015). The gradual immunodeficiency caused by the virus allows proliferation of infections and
diseases, outcomes that would not occur in people with a healthy immune system (CDC, 2015).
Acquired Immunodeficiency Syndrome (AIDS) is the most advanced stage of HIV infection.
Without aggressive antiretroviral treatment, people with HIV can develop AIDS within two to 15
years. Certain cancers, infections, or other manifestations of the infection define AIDS and its
ultimate outcome is death (WHO, 2014b).
HIV transmission occurs through exchange of bodily fluids from an infected individual,
such as blood, breast milk, and genital secretions. Mother-to-child transmission can occur during
pregnancy, labor, or breastfeeding (CDC, 2015). In the absence of interventions, the transmission
rate for HIV from mother to child is between 15 and 45% for the sum of these routes (WHO,
2010; WHO, 2014a). Transmission can be significantly prevented or reduced through the use of
antiretroviral medications (ARVs) (CDC, 2015). The current WHO recommendation (2014a)
includes ARV provision to mothers and infants during pregnancy, delivery, breastfeeding, and
life-long treatment for the mother. It was estimated in 2013 that 67% of the 1.4 million pregnant
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2014b). This is a significant increase from 47% in 2009 (WHO, 2014b).
Breastfeeding imparts significant health benefits for children and is an important
intervention to improve child mortality rates. However, there is also a risk of HIV transmission
when an HIV-positive woman breastfeeds her child. There is a balance to be struck between the
benefits and the risk of transmission of HIV by a woman with HIV. The risk of HIV-infection
must be compared with the risk of morbidity and mortality from causes that are prevented by
breastfeeding (UNICEF, 2005). Infants who are not breastfed are more than 14 times more likely
to die of an infectious disease like diarrhea or respiratory infection than an infant who is
exclusively breastfed for six months (UNICEF, 2005).
The World Health Organization recommends exclusive breastfeeding for six months and
continuing with complementary feeding for up to two years (WHO, 2003). Breastfeeding has
several proven and important benefits for the mother and infant. Breast milk provides food and
improves the nascent immunity of an infant due to antibodies from the mother (WHO, 2003). In
a meta-analysis on the other benefits and effects of breastfeeding, breastfeeding was associated
with a reduction in a child’s risk of ear infections, stomach infections, asthma, obesity, eczema,
lung infections, childhood leukemia and sudden infant death syndrome (SIDS) (Ip et al., 2007).
Overall, six months of exclusive breastfeeding could result in a 13% reduction in childhood
mortality under the age of 5, including reducing sudden infant death syndrome (SIDS),
infections, and diarrhea (American Academy of Pediatrics, 2012; WHO, 2013).
The first recommendations for infant feeding when the mother is known to be infected
with HIV were made in 1985 and said to avoid breastfeeding (CDC, 1985). Replacement feeding
for an infant is necessary if a woman chooses not to breastfeed, and formula feeding is a
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including the need for resources like clean water and the lack of immune components present in
breast milk. The widespread availability of ARVs has changed the recommendations so that
exclusive breastfeeding is recommended for six months with the continuation of breastfeeding
for at least 12 months while taking ARVs (WHO, 2010; WHO, 2014a).
Importantly, exclusive breastfeeding for the first six months of life is associated with a
three to four-fold decrease in the risk of HIV transmission when compared to mixed feeding
(UNICEF, 2005). Mixed feeding refers to giving the infant something other than only breast
milk, including any other food, water, or formula before six months of age (UNICEF, 2005).
Exclusive breastfeeding rates among children who are less than six months of age have been
generally increasing since the 1980s (UNICEF, 2005). In sub-Saharan Africa where the some of
most common causes of infant and child mortality are infectious diseases, increasing the rates of
exclusive breastfeeding would help prevent many infant deaths from infectious diseases
(UNICEF, 2005). The evidence now shows that HIV transmission can also be reduced if HIVpositive women exclusively breastfed for six months rather than practicing mixed feeding.
Public health has a major role in promoting, protecting, and supporting of breastfeeding
globally (UNICEF, 2005). Global goals for breastfeeding have been established by the United
Nations (2008) in the Millennium Development Goals, which were intended to be achieved by
2015. For HIV, these goals include decreasing under-five mortality, halting and reversing the
spread of HIV/AIDs, and achieving universal access to treatment for HIV/AIDS (United Nations,
2008). Other countries have established goals for breastfeeding, including the Healthy People
2020 goals in the United States (United States Department of Health and Human Services
[HHS], 2011). Although the prevalence of HIV in the United States is relatively low, increasing
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benefits. For example, the goal for the initiation of breastfeeding is an increase from the baseline
of 74.0 in 2009 to 81.9% (HHS, 2011).
Purpose Statement
Increasing breastfeeding rates and reducing HIV/AIDS are two important global health
priorities, and the intersection of these two has led to the development of policies and guidelines
for infant feeding. The World Health Organization has released many documents since the
discovery of HIV to provide recommendations and guidance on infant feeding and the risk of
transmission through breastfeeding. This analysis explores the intersection of HIV and infant
feeding policies. It provides a historical, chronological perspective on the global policies for
infant feeding in the case of an HIV-positive mother, an analysis of changes, and
recommendations for the future.
Policy Analysis
A History of Policies Concerning Breastfeeding by Mothers with HIV
Each of the major WHO policies for infant feeding in the setting of HIV are evaluated in
chronological order (Figure 1) and are followed by a summary, changes, and importance of the
policies.

1981 1985 1987

1992

1998 2001 2004 2007 2010 2012 2014 Today

Figure 1: Timeline of policies; each time point on this timeline indicates a new policy or revision
by the World Health Organization.
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1981: First reports of the condition that will become HIV/AIDS and WHO’s enactment
of the International Code of Marketing of Breast Milk Substitutes.
The Morbidity Mortality Weekly Report (CDC, 1981) published a report that was later
recognized as the first scientific publication on HIV. There was also an article published in the
New York Times (Altman, 1981) addressing cancer found in homosexual men, then thought to
be the only group affected. At the time, the name for HIV had not been established, and very
little was known about the disease beyond the case reports.
Meanwhile, breastfeeding was being promoted and protected in an unprecedented way
through international health policy framework in the WHO’s International Code of Marketing of
Breast-Milk Substitutes ratified in 1981. This policy recommended healthcare workers
encourage and support breastfeeding and restricted formula marketing to ensure that mothers
were not discouraged from breastfeeding (WHO, 1981).
Importance. This was the start of the HIV/AIDS epidemic and the onset of the fight
against the global spread of HIV. Breastfeeding was also emerging as a public health priority,
and the International Code was the first broad attempt to address the ethical issues in promoting
milk substitutes in competition with human milk (WHO, 1981). It remains an important tool in
protecting the health of mothers and babies worldwide. The intersection of HIV and
breastfeeding was not yet established.
1985: First report on HIV transmission risk from breast milk.
The first article to discuss suspected HIV transmission through breast milk was released
in a Morbidity Mortality Weekly Report in 1985 (CDC, 1985). The summary of case reports and
research established the belief that HIV could be transmitted to a fetus (see Figure 2). There was,
however, no discussion of the potential mechanism for transmission, although women infected

HIV AND BREASTFEEDING IN GLOBAL POLICY
with HIV were advised against breastfeeding (CDC, 1985). HIV counseling and testing was

10

encouraged in populations thought to have a higher prevalence of HIV/AIDS, including: women
who had used intravenous drugs; were born in a country with high heterosexual transmission;
had engaged in prostitution; had partners who abused intravenous drugs; were bisexual; had
hemophilia; or had the virus (CDC, 1985). Furthermore, counseling and testing was
recommended only for these groups, not for pregnant women (CDC, 1985).
It is believed that [HIV] is transmitted from infected women to their fetuses or offspring during
pregnancy, during labor and delivery, or perhaps shortly after birth… breastfeeding is [a]
possible mode of transmission. (p. 722)
[HIV]-infected women should be advised against breastfeeding to avoid postnatal transmission
to a child who may not yet be infected (p. 725)
Figure 2: Language from the Morbidity Mortality Weekly Report published in 1985 that first
established a potential risk of HIV transmission through breast milk.
Source: CDC, 1985
Importance. This appears to be the first entry in the literature that included information
on mother-to-child transmission. It is a vague description without specific recommendations, but
it is the first published summary of knowledge to date linking HIV and breastfeeding.
1987: The first global recommendation on HIV and breastfeeding.
The first global policy from the World Health Organization (WHO) was published in
1987. Figure 3 states the policy’s uncertainty about breastfeeding and the risk of HIV
transmission (WHO, 1987). The policy emphasized that breast milk should continue to be
promoted in all health and nutrition policies for its benefits in improving overall health of mother
and child. Pasteurization of pooled milk was recommended, and the screening of donors was to
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known and potential benefits of breastfeeding should be compared to the theoretical, but
apparently small, incremental risk to the infant of becoming infected through breastfeeding”
(WHO, 1987, p. 2). Alternatives for infant feeding were recommended to be considered given
the woman’s socioeconomic status and available resources in the environment (WHO 1987).
At present, the risk of HIV transmission from mothers to infants through breast-feeding
has not been defined, but available information suggest that if such transmission occurs,
the relative contribution of this route is probably small, compared with in utero and
intrapartum transmission. (WHO, 1987, p.1).
In many circumstances and, particularly, where the safe and effective use of alternatives
is not possible, breastfeeding by the biological mother should continue to be the feeding
method of choice, irrespective of her HIV infection status. (WHO, 1987, p.2)
Figure 3: Text taken verbatim from the 1987 WHO policy that illustrates the uncertainty about
HIV transmission via breastmilk.
Changes. The major change was the creation of a global policy released by the WHO and
the magnitude of HIV transmission risk through breast milk was stated to be smaller than that or
in utero or postpartum transmission. There were no citations of published research that were used
for the foundation of the policy, although the policy states: “the possibility that HIV could be
transmitted through breastfeeding/breast milk is supported by a report that HIV can be cultured
from breast milk from mothers who are themselves infected” (WHO, 1987, p.1).
From a public health perspective, it is important to note that there is no definition given
for “safe” or “effective” for the use of milk alternatives
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Importance. This policy discusses the transmission of HIV through breast milk as well as
the balance of importance of breastfeeding versus the risk of transmission. This debate continues
throughout all future policies.
1992: Consensus statement from the WHO/UNICEF consultation on HIV
transmission and breastfeeding.
The next recommendations from the WHO were provided in a consensus statement
released in 1992. At the time of this document, approximately one-third of infants born to HIVinfected women were infected, the majority of which were infected during pregnancy and birth
(WHO, 1992). HIV transmission through breastfeeding was viewed as most prevalent in women
who became infected post-partum and lower in women that were already infected at the time of
labor and delivery (WHO, 1992).
There was uncertainty about the magnitude of risk; however, breastfeeding continued to
be acknowledged as providing notable nutritional, immunological, psychosocial, and maternal
benefits (see Figure 4) (WHO, 1992). The WHO also promoted the creation of individual
country guidelines and assessment individual women’s circumstances to create those tailored
guidelines (WHO, 1992).
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Recommendations:
1. In all populations, irrespective of HIV infection rates, breastfeeding should continue to be
protected, promoted and supported.
2. Where the primary causes of infant deaths are infectious diseases and malnutrition, infants
who are not breastfed run a particularly high risk of dying from these conditions. In these
settings, breastfeeding should remain the standard advice to pregnant women, including
those who are known to be HIV-infected, because their baby’s risk of becoming infected
through breast milk is likely to be lower than its risk of dying of other causes is deprived of
breastfeeding…
3. In settings where infectious diseases are not the primary cause of death during infancy,
pregnant women known to be infected with HIV should be advised not to breastfeed but to
use a safe feeding alternative for their babies…
4. When a baby is to be artificially fed, the choice of substitute feeding method and product
should not be influenced by commercial pressures…
5. HIV-infected women and men have broad concerns, including maintaining their own health
and well-being, managing their economic affairs, and making future provision for their
children, and therefore require counseling and guidance on a number of important issues…
6. In all countries, the first and overriding priority in preventing HIV transmission from
mother to infant is to prevent women of childbearing age from becoming infected with HIV
in the first place… (p.1-2)
Figure 4: Text excerpted from the WHO consensus statement published in 1992.
The 1992 WHO consensus statement included statements that breastfeeding should be
“protected, promoted, and supported” regardless of HIV infection rates. In countries where infant
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standard. Breastfeeding was asserted to be protective against infectious diseases and other
common causes of infant mortality. In settings where infectious diseases were not the most
common cause of death in infants, HIV-infected women were advised against breastfeeding.
Changes. This statement was more specific regarding transmission and recommendations
than the 1987 policy. Definitions for “safe feeding alternatives” were still not included (WHO,
1987, p.2). In an expansion of the previous recommendations, women with unknown HIV status
were encouraged to breastfeed. Prevention of women becoming infected with HIV was the
superseding priority in this policy.
Importance. This appears to be the first WHO statement to specifically address women
with an unknown HIV status. It was also unique in its separation of countries with high infant
mortality risk from infectious sources from those without. There is a continued
acknowledgement of the need for balance between the risk of HIV transmission to the infant and
the benefits of breastfeeding.
1998: UNICEF-USAID-WHO HIV and infant feeding: a review of HIV transmission
through breastfeeding.
The next policy from the WHO and the Joint United Nations Program on HIV/AIDS was
in 1998. In a summary of data, the overall risk of HIV transmission during pregnancy, delivery
and breastfeeding was identified as 25 to 45%, which estimated the additional risk of
transmission from breastfeeding of at least 15%. This policy identified HIV as being transmitted
though breast milk, citing multiple published scientific studies (Joint United Nations Program on
HIV/AIDS [JUNPOHA], 1998, p.7). Factors thought to be responsible for the variation in rates,
including maternal nutrition, high viral load, and low CD4 count, were also included
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transmission of HIV throughout the duration of nursing. It introduced the idea that mixed feeding
could confer a higher risk than exclusive breastfeeding supported by three published scientific
studies (JUNPOHA, 1998, p.12). There was an inclusion of identified barriers to replacement
feeding included: stigma, affordability, increased risk of infection, and increased risk of
malnutrition.
Strategies to reduce breast milk transmission included primary prevention of HIV,
replacement feeding, early cessation of breastfeeding, treatment of breast milk, wet-nursing by a
HIV-negative women, and antiretroviral therapy (see Figure 5). If “adequate” replacement
feeding was not possible, three other strategies were suggested. The term “adequate” was not
defined. The first strategy was exclusive breastfeeding followed by “early cessation” of
breastfeeding (JUNPOHA, 1998, p.14). Cessation was described as the discontinuation of
breastfeeding with a transition to replacement feeding, either formula or food depending on the
age of the infant (JUNPOHA, 1998, p. 14). There was no definition for the timing of when this
“early cessation” should begin or how long the transition should take. It was thought that early
cessation would limit exposure to HIV through breast milk and therefore transmission risk.
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Where adequate replacement feeding is not possible, mothers may choose among three other
strategies to reduce the risk of breast milk transmission:
-

Exclusive breastfeeding followed by early cessation of breastfeeding. Early cessation of
breastfeeding may reduce exposure and hence the risk of breast milk transmission, while
not eliminating the risk entirely, as the infant remains exposed for the first few months

-

Heath treatment of expressed breast milk

-

Wet-nursing by a tested HIV-negative woman (JUNPOHA, 1998, p. 14).

Figure 5: Text excerpted from the 1998 policy describing the strategies to reduce HIV
transmission through breast milk.
The second strategy called for heat treatment of expressed breast milk because
pasteurization has been demonstrated to reduce the quantity of HIV (JUNPOHA, 1998, p. 1415). A concern with this process was the difficulty sustaining the process of expressing breast
milk. It was suggested to be a viable option as a temporary solution during periods of increased
HIV transmission risk, including in the case of cracked nipples, mastitis or abscess (JUNPOHA,
1998). Heat treatment and HIV screening was recommended for all milk banks. The third option
was for a confirmed HIV-negative woman to serve as a wet nurse.
Antiretroviral therapy (ART) was discussed for the first time in this policy. Multiple
studies cited had demonstrated the reduction of mother-to-child transmission through the use of
maternal ART. However, it had not yet been studied in breastfed infants and clinical trials were
being conducted.
Changes. This document’s superseding goal was a continuation of the previous policies,
specifically the protection and promotion of breastfeeding. This was the first time risk factors
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associated with an increased mother-to-child transmission of HIV were discussed in the
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framework of “strong evidence” and “limited evidence” (WHO, 1998, p. 11).
Overall, research evidence was more prominent and cited for the first time. There was
increased identification of the gaps in knowledge and research. It is notable that there was still no
definition of adequate replacement feeding provided. There was also no definition or guideline
for early cessation of breastfeeding, and no optimal time for the length of breastfeeding or
cessation of breastfeeding was identified.
In addition, this is the first time that ARVs were mentioned in the policies related to
breastfeeding. ARVs were introduced in 1995-1996, and their availability was a significant
advancement for HIV treatment and prevention (Palella et al., 1998). At the time of this policy,
ARVs were being investigated for their use in the context of breastfeeding, and there was not
enough conclusive evidence to form recommendations at the time (see Figure 6).
“Since many HIV-infected mothers may face obstacles to replacement feeding- for example,
stigma, affordability, risk to the mothers/or breastfed infants, with and without a postnatal
treatment component, the effectiveness of antiretroviral treatment of breastfeeding mothers/or
breastfed infants, with and without a postnatal treatment component, is an important research
question” (p. 15).
Figure 6: Text taken verbatim from the 1998 policy highlighting the need for research on the use
of ARVs in breastfeeding mother-infant dyads.
Importance. For the first time, there was an inclusion of cited evidence. There was a
discussion of current evidence, gaps in knowledge, and further research questions. In addition,
ARVs were an important new tool in the fight against global HIV. Although there was no
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recommendation for the use of ARVs in the setting of infant feeding or breastfeeding, they were
an important inclusion and prequel to the next policy.
2000: New data on the prevention of mother-to-child transmission of HIV and their
policy implications – conclusions and recommendations.
In 2000, there was a release of another document from the WHO and other United
Nations partners (Inter-Agency Task Team on Mother-to-Child Transmission of HIV [IATT],
2000). The risk of HIV transmission via breast milk was quantified with a citation of three

studies. “In untreated women who continue breastfeeding after the first year, the absolute risk of
transmission through breastfeeding is 10-20%” (IATT, 2000, p.11). Breastfeeding furthermore
carried a significant risk of HIV transmission that varied based on several factors, possibly
including the pattern and duration of breastfeeding. ARVs were recommended as a prophylactic
regimen for pregnant women for the first time, but there were still no guidelines for use in the
context of breastfeeding.
Recommendations (see Figure 7) included milk replacement feeding (i.e. formula) when
it is “acceptable, feasible, affordable, sustainable, and safe” (IATT, 2000, p.12), which is
commonly referred to by the acronym AFASS. It was further recommended if these conditions
could be met, avoidance of all breastfeeding by HIV-positive mothers was recommended.
Breastfeeding cessation was recommended to stop as soon as the AFASS criteria could be met
(Figure 6). In addition, periods of mixed feeding were recommended to be kept as short as
possible to limit the increased risk of transmission that occurs due to mixed feeding.
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Implementation of any of the antiretroviral prophylaxis regimens shown to be effective in
randomized clinical trials… can be recommended for general implementation (p. 9).
When replacement feeding is acceptable, feasible, affordable, sustainable, and safe, avoidance of
all breastfeeding by HIV-infected mothers is recommended.
Otherwise, exclusive breastfeeding is recommended during the first months of life.
To minimize HIV transmission risk, breastfeeding should be discontinued as soon as feasible,
taking into account local circumstance, the individual woman’s situation and the risks of
replacement feeding (including infectious other than HIV and malnutrition).
When HIV-infected mothers choose not to breastfeed from birth or to stop breastfeeding later,
they should be provided with specific guidance and support for at least the first 2 year of the
child’s life to ensure adequate replacement feeding. Programs should strive to improve
conditions that will make replacement feeding safer for HIV-infected mothers and families (p.
12).
Figure 7: Recommendations cited verbatim from the 2000 IATT policy recommendations.
The recommendation for the timeline of cessation was still unspecified, but this policy
stated that the timing could vary depending on various factors, including age of the infant and the
preferences of the mother and infant. Women with HIV were to be provided professional
guidance and support while discontinuing breastfeeding to minimize negative nutritional,
psychological, and breast health consequences for the mother and/or infant. All HIV-positive
mothers were to be counseled with general information on the risks and benefits of all feeding
options, including specific guidance in selection of the best option based on their situation (see
Figure 8). The woman’s choice was emphasized as the priority for support. AFASS options were
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encouraged to be evaluated at the local level based on various circumstances and considerations
prior to the provision of counseling.
All HIV-infected mothers should receive counseling, which includes provision of general

information about the risks and benefits of various infant feeding options, and specific guidance
in selecting the option most likely to be suitable to their situation. Whatever a mother decides,
she should be supported in her choice (IATT, 2000, p.13)
Figure 8: Text excerpted from the 2000 IATT policy on the recommendation for counseling
HIV-positive mothers.
Changes. Breastfeeding was again asserted as a source of complete nutrition for infants
and should be protected, promoted and supported. Notably, the WHO asserted that standards in
developed countries may not be safe or practical in developing countries. This was the first time
that the AFASS criteria were identified as a group, although definitions were vague. Mixed
feeding was discouraged based on cited evidence of increased risk for the first time; previous
policies asserted this without evidence (IATT, 2000, p.11). The counseling recommendation
changed slightly to include “specific guidance” of the option that was most likely to work for the
individual (IATT, 2000, p.12), rather than a presentation of all the options and allowing the
mother to choose. In addition, the prophylactic use of ARVs was recommended for the first time.
Importance. The use of ARVs in a prophylactic regimen for pregnant women was
introduced in this document. The policy was also the first to describe the risks of feeding milk
replacement products instead of breast milk. However, by using the AFASS acronym, this policy
implied that milk substitutes could be made “safe” by some unstated standard. The AFASS
criteria were an advance in the recommendations for the consideration of replacement feeding,
but it was inadequate and did not provide specific definitions. In addition, the shift in counseling
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to allow for specific recommendations created a reliance on the local level estimation of relative
risks, and it introduced the potential for bias in counseling toward one feeding method over
another.
2004: HIV transmission through breastfeeding – a review of available evidence.
In 2004, the WHO issued a review of the HIV transmission through breastfeeding. This
document was consistent with previous policies and clearly stated the risk/benefit balance
consideration at hand: “The main current public-health research question is whether
breastfeeding by HIV-infected mothers can be made safer as to transmission risk, given the
possible adverse effects of refraining from breastfeeding” (WHO, 2004, p. 2). Exclusive

breastfeeding was recommended for the first six months of infant life followed by a transition to
replacement feeding as soon as it could be made AFASS (see Figure 9). The HIV transmission
risk before or during birth (without interventions) was stated to be 15 to 25%; breastfeeding was
said to increase the risk of transmission to the infant by 5 to 20% (WHO, 2004, p.1).
“The best means of preventing HIV infection in infants and young children, including
transmission through breast milk, is to prevent HIV infection of female adolescents and women
of childbearing age”
“… infants should be exclusively breastfed for the first six month of life to achieve optimal
growth, development and health. After six months, they should receive nutritionally adequate
and safe complementary foods while breastfeeding continues up to 24 months of beyond” (WHO,
2004, p.16)
Figure 9: Text excerpted from the 2004 WHO review of available evidence.
ARVs were still being investigated for the safety and efficacy for the breastfed infant.
Risk of HIV transmission was reported to be reduced through the use of Caesarean deliveries and
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ARVs during pregnancy and delivery. ARVs were becoming more prominent with more research
available and being conducted. This was also the first time Caesarean deliveries were mentioned
specifically in the prevention of HIV transmission.
Breastfeeding was recommended unless an alternative met the AFASS criteria, yet
specific definitions for AFASS criteria continued to be vague. Mothers were advised to stop
breastfeeding after the infant reached six months of age or as soon as replacement feeding was
AFASS (Figure 9).
Changes. Although the use of ARVs was introduced in the 2001 policy, there were still
no recommendations for ARV use in breastfeeding mothers and infants in the 2007 update.
Overall, this policy served as an update of available evidence and cited an increasing amount of
research.
Importance. This document primarily served as an evidence update for the previous
policy .However, there are still no recommendations for ARVs for breastfeeding mothers and
infants in this 2004 document. The ongoing trials were noted, but no definitive conclusions were
yet possible. The focus on HIV prevention in women in their reproductive years is an important
part of this public health document, providing a basis for prevention policy.
2007: Guidance on global scale-up of the prevention of mother-to-child transmission
of HIV.
In 2007, the Interagency task team (IATT) on the prevention of mother-to-child
transmission of HIV released a document intended for organizations and the international
community addressing the factors that affect prevention of mother-to-child transmission
(PMTCT) of HIV, including weak health systems, political will, and mobilization of resources
(see Figure 10). The IATT stressed that access to and use of quality antenatal, delivery and
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had established national coverage PMTCT programs, and the goal of this document was the
increasing the global availability for programs to prevent mother-to-child transmission of HIV.
Recommended Priority Strategies and Actions at Country Level:
1. Demonstrated government leadership, commitment and accountability to deliver on the
goal of universal access to PMTCT and HIV care for children…
2. District- driven delivery of a standard package of comprehensive services…
3. Institutionalizing provider-initiated HIV testing and counseling in maternal, newborn and
child health settings…
4. Institutionalizing longitudinal HIV care management in maternal, newborn and child
health settings
5. Increasing access to antiretroviral therapy for pregnant women, mothers, and their
children and families in the context of PMTCT…
6. Strengthening infant feeding and nutrition advice, counseling and support for women and
their children and families in the context of PMTCT and HIV care for children…
7. Operationalizing the link between the delivery of PMTCT and of sexual and reproductive
health care…
8. Empowering and linking with communities…
Figure 10: Text cited verbatim from the 2007 IATT guidelines outlining recommended priority
strategies and actions.
Changes. This document included specific goals and outcomes to guide the global effort
for PMTCT. Although previous global goals existed (e.g. the Millennium Development Goals),
these goals were specifically related to mother-to-child transmission of HIV. There was an

HIV AND BREASTFEEDING IN GLOBAL POLICY
increased recognition of the need of operationalization of the guidelines and the integration of

24

health care services, a key point that served as a call to improved implementation.
Importance. This document provided specific numerical and programmatic goals related
to the prevention of mother-to-child transmission for the first time. This document contained
recommendations for and enumerated specific goals to be achieved by the various stakeholders.
This clarity and specificity provided standard goals for the global community to strive toward.
2007: HIV transmission through breastfeeding - a review of available evidence 2007
update.
In 2007, the WHO updated its policy again, emphasizing the “pressing public health
dilemma” of reducing HIV transmission (WHO, 2007, p.1). The policy stated estimated HIV
transmission rate of 5-10% from breastfeeding between birth and six months and 15 to 20%
between birth and 18 to 24 months (WHO, 2007). Overall, the risk of postnatal HIV transmission
was estimated to be 1% per month of breastfeeding, and it was now described as remaining
constant from one month to 18 months of age (WHO, 2007).
The 2007 recommendations assert that the most appropriate feeding method chosen by
the mother should depend on her circumstances, including health, environment, and resources.
There is an emphasis on informed choice and appropriate counseling that includes all options
“based on local assessments and guidance in selecting the most suitable option for their own
situation” (WHO, 2007, p.2). Early cessation of breastfeeding was no longer recommended
based on several studies that report that early cessation was associated with an increase in infant
morbidity (WHO, 2007). Other stated possibilities to prevent transmission through infant feeding
included maternal ART and post-exposure prophylaxis for the infant, although these protocols
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(WHO, 2007).
These guidelines demonstrated a continued increase in the evidence cited and used for
recommendations. They continued to assert the need for a balance of risks and benefits between
breastfeeding and replacement feeding (see Figure 11). To aid in this balance, individual
countries were recommended to establish national feeding policies that consider the risks of
transmission of HIV in the HIV population while protecting, promoting, and supporting
breastfeeding in the general population. Furthermore, there was a goal to ensure that pregnant
women receive HIV prevention services. At the time of the recommendations, less than 10% of
women with HIV had access to appropriate care (WHO, 2007, p.4).
• While breastfeeding carries the risk of HIV transmission, not breastfeeding carries other
significant health risks to infants and young children, such as an increased risk of diarrhea
and pneumonia morbidity and mortality (WHO, 2007, p.4).
• In considering replacement feeding, the following conditions are critical: sustainable access
to clean water; regular postnatal follow-up (with repeated growth monitoring); nutritional
counseling; and drugs and supplies at no cost or at a subsidized price, and with a controlled
distribution (WHO, 2007, p. 43).
• These restrictive and selective conditions serve to remind that formula feeding could be an
option to replace breastfeeding but is far from being applicable in all settings; thus, the need
for more studies on alternative strategies for breastfeeding (e.g. antiretroviral prophylaxis)
(WHO, 2007, p. 33).
Figure 11: Important excerpts from the 2007 WHO policy highlighting the updated risk/benefit
considerations for breastfeeding by HIV-positive mothers.
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replacement feeding could meet the AFASS criteria. When these conditions existed,
breastfeeding was to be avoided, and consideration of the AFASS criteria was critical when
terminating breastfeeding or when the mother or infant’s situation changes.
Changes. Overall, the 2007 policy provided greater evaluation of current studies,
consideration of confounding factors, and specific directions needed for further research.
Recommendations for the feeding of HIV-positive infants were included for the first time.
Global practices were also discussed, including the fact that nearly all infants in developing
countries were at least partially breastfed. Non-exclusive breastfeeding was found to be common,
which added a challenge to the promotion and recommendation of exclusive breastfeeding for
infant health.
The heat-treatment of expressed milk was now considered to be an interim option. In
2000, the heat-treatment of breast milk was considered a main option for preventing the
transmission of HIV to infants through breast milk. By 2006, it was no longer considered main
option. It was instead considered to be an option while transitioning from breast milk to
replacement feeding.
Recommended strategies included in the document emphasized the continued need for
primary prevention and prevention of postnatal transmission. Women were recommended to be
given all the relevant information needed to make informed decisions about safely feeding their
infant. Settings vary in the acceptance of breastfeeding or formula feeding, and interventions
need to be based on evaluations of local health services and individual circumstances (WHO,
2007, p. 43). It was also acknowledged that replacement feeding requires resources, including
adequate fuel, access to a refrigerator, clean water, and financial means.
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acceptability, and effectiveness, elements of the AFASS criteria. There was also the statement
that policy must be considered in terms of the intended effect on the population as well as social
acceptability and the potential effect on the general population. Effectiveness requires
documentation, and it is important to evaluate the success of an intervention in meeting its
objectives. HIV-survival was introduced as a defined term that refers to children who are both
alive and HIV-free at a given age, usually 18 months. This was described as a valuable index to
evaluate interventions and the most reliable and easy way to determine long-term success of an
intervention.
ART was again discussed as a future subject of policy. There were increasing amounts of
evidence, but it was still not possible to make a specific recommendation for antiretroviral
medication given to women or infants for the prevention of HIV transmission during
breastfeeding.
Importance. This policy’s introduction of HIV-survival as a defined term and a
measurable outcome was a distinct improvement over previous policies’ vague discussions of
balancing risks and benefits. While the onus for decision-making remained on the local
healthcare providers and the mother, this policy gave more specific information on what should
be part of that local evaluation. The definitions for AFASS, introduced in 2001, were more
clearly defined.
2010: Guidelines on HIV and infant feeding - principles and recommendations for
infant feeding in the context of HIV and a summary of evidence.
The 2010 WHO guidelines brought another important shift in policy. The majority of
recommendations in this document are consistent with previous recommendations, but a new
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evidence-based recommendation for ART said it should be provided to either the breastfeeding
mother or infant. National authorities were encouraged to determine which infant feeding
practice would be promoted and protected, rather than presenting neutral information for the
mother to then make the choice based on individual counseling with all the options (WHO,
2010). The options were either to breastfeed while the mother or infant received ARVs or to

avoid all breastfeeding. The AFASS criteria for replacement feeding were further clarified with
more common language and more explicit definitions.
The 2010 WHO guidelines included nine key principles which were intended to provide
context for the provision of care to infants and HIV-positive mothers (see Figure 12). These
principles enumerated the various considerations for the prevention of mother-to-child
transmission of HIV and the protection of infants.
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Key Principle 1: Balancing HIV prevention with protection from other causes of child mortality. Infant feeding
practices recommended to mothers known to be HIV-infected should support the greatest likelihood of HIV-free
survival in their children and not harm the health of mothers. To achieve this, prioritization of prevention of HIV
transmission needs to be balanced with meeting the nutritional requirements and protection of infants against nonHIV morbidity and mortality.
Key Principle 2: Integrating HIV interventions into maternal and child health services. National authorities
should aim to integrate HIV testing, care and treatment interventions for all women into maternal and child health
services. Such interventions should include access to CD4 count testing and appropriate antiretroviral therapy or
prophylaxis for the woman’s health and to prevent mother-to-child transmission of HIV.
Key Principle 3: Setting national or sub-national recommendations for infant feeding in the context of HIV.
National or sub-national health authorities should decide whether health services will principally counsel and
support mothers known to be HIV-infected to either breastfeed and receive ARV interventions or avoid all
breastfeeding. This decision should be based on international recommendations and consideration of the: socioeconomic and cultural contexts…; availability and quality of health services; local epidemiology including HIV
prevalence among pregnant women; main causes of maternal and child undernutrition; main causes of infant and
child mortality.

Key Principle 4: When antiretroviral drugs are not (immediately) available, breastfeeding may still provide
infants born to HIV-infected mothers with a greater chance of HIV-free survival. Every effort should be made to
accelerate access to ARVs for both maternal health and also prevention of HIV transmission to infants. While ARV
interventions are being scaled up, national authorities should not be deterred from recommending that HIV-infected
mothers breastfeed as the most appropriate infant feeding practice in their setting. When a national authority has
decided to promote and support breastfeeding and ARVs, but ARVs are not yet available, mothers should be
counseled to exclusively breastfeed in the first six months of life and continue breastfeeding thereafter unless
environmental and social circumstance s are safe for, and supportive of replacement feeding. In circumstances were
ARVS are unlikely to be available, such as acute emergencies, breastfeeding of HIV-exposed infants is also
recommended to increase survival.
Key Principle 5: Informing mothers known to be HIV-infected about infant feeding alternatives. Pregnant women
and mothers known to be HIV-infected should be informed of the infant feeding practice recommended by the
national or sub-national authority to improve HIV-free survival of HIV-exposed infants and the health of HIVinfected mothers, and informed that there are alternatives that the mother might wish to adopt.
Key Principle 6: Providing services to specifically support mothers to appropriately feed their infants. Skilled
counseling and support in appropriate infant feeding practices and ARV interventions to promote HIV-free survival
of the infants should be available to all pregnant women and mothers.
Key Principle 7: Avoiding harm to infant feeding practices in the general population. Counseling and support to
mothers known to be HIV-infected, and health messaging to the general populations, should be carefully delivered
so as not to undermine optimal breastfeeding practices among the general population.
Key Principle 8: Advising mothers who are HIV uninfected or whose HIV status is unknown. Mothers who are
known to be HIV uninfected or whose HIV status is unknown should be counseled to exclusively breastfeed their
infants or the first six months of life and then introduce complementary foods while continuing breastfeeding for 24
months and beyond.
Key Principle 9: Investing in improvement in infant feeding practices in the context of HIV. Governments, other
stakeholders and donors should greatly increase their commitment and resources… (WHO, 2010, p. 16-28)

Figure 12: The nine key principles of infant feeding in the context of HIV.
Note: Taken verbatim from WHO, 2010.
Changes. While the 2010 guidelines are generally consistent with previous guidance,
there are both minor and major changes. Minor changes include more specific recommendations
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and children and the recommendation for breastfeeding in the setting of acute emergencies.
There was an acknowledgment that women need health care services to remain HIV-free. The
2010 guidelines consider heat treatment of breast milk to be an option for when a mother is
temporarily unable to breastfeed or as an option as she is transitioning away from breastfeeding.
This policy contained more specific options and guidelines for mothers.
Major changes include the fact that Governments and stakeholders were addressed
directly and explicitly advised to provide services and interventions for the prevention and
treatment of HIV (Key Principle 9, Figure 12). This was included to “remind national and
international agencies of their responsibilities to all mothers and infants, irrespective of their HIV
status and the convergence between global health agendas” (WHO, 2010, p. 28). This policy
attempted to remind the global health community of the necessity to coordinate the various goals
that have been established locally and internationally.
The major changes introduced in this policy include the recommendations regarding
counseling, ARV use, and the duration of breastfeeding. Previous guidelines provided general
information on all risks and benefits to each HIV-positive pregnant and postpartum woman.
Despite an emphasis on individual rights, there was a clear endorsement in this policy for
national recommendations that principally counsel and support a single standard
recommendation. There appears to be less emphasis on individual choice and recommendations
for individual circumstances. One key reason for the decision for one primary recommendation
was stated as, “If there is a medical consensus in favor of a particular option, the reasonable
patient would prefer a recommendation rather than simply a neutral presentation of options, as
was recommended in previous WHO guidance” (WHO, 2010, p.19). However, despite the
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single approach was considered to be appropriate for all settings. The clear message was to
provide standard recommendations and counsel individuals on how those might be adapted to
individual circumstances.
The recommendation for ARV provision to the mother or child during breastfeeding was
another significant addition to the guidelines. Although ARVs had a fifteen-year history, no
previous policy provided recommendations for antiretroviral use while breastfeeding. In settings
where infectious diseases and malnutrition were major causes of infant mortality, ARVs in
combination with breastfeeding were recommended. ARVS were recommended in this policy to
be provided as lifelong therapy to the mother.
Several new specifications concerning the duration and timeframe of breastfeeding were
established in this policy. Cessation was recommended to be conducted gradually within a month
when mothers decide to stop at any time, which is a definite timeline for the first time. ARV
prophylaxis to the mother or infant was to continue for one week after breastfeeding fully
stopped. There was no previous recommendation on ARV prophylaxis during cessation. There
were also specific recommendations for alternatives to breast milk. The AFASS criteria for
replacement feeding were substituted with more common language and more explicit definitions
as well (see Figure 13).
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“Mothers known to be HIV-infected should only give commercial infant formula milk as a
replacement feed to their HIV-uninfected infants or infants who are of unknown HIV status,
when specific conditions are met:
a. Safe water and sanitation are assured at the household level and in the
community, and; b. the mother, or other caregiver can reliably provide sufficient
infant formula milk to support natural growth and development of the infant; and,
c. The mother or caregiver can prepare it cleanly and frequently enough so that it is
safe and carries a low risk of diarrhea and malnutrition; and
d. The mother or caregiver can, in the first six months, exclusively give infant
formula milk; and,
e. The family is supportive of this practice; and
f. The mother or caregiver can access health care that offers comprehensive child
health services” (p.7-8).
… It was considered that such language would better guide health workers regarding what
to assess, and to communicate this to mothers who were considering if their home
conditions would support safe replacement feeding” (p. 37).
Figure 13: Verbatim text from the 2010 WHO policy describing standards for AFASS criteria.
The guidelines were changed to recommend breastfeeding exclusively for six months
followed by the addition of appropriate complementary foods and the continuation of
breastfeeding for the first 12 months of life (see Figure 14). The recommendation for the
continuation for 12 months is a distinct change from the previous recommendations for cessation
as soon as the AFASS criteria could be met or after achieving 6 months of exclusive
breastfeeding. The 12-month recommendation was based on evidence that “twelve months
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this combination [with ARVs] would offer the best balance of protection from morbidity and
mortality versus the risk of HIV transmission” (WHO, 2010, p. 32).

“Mothers known to be HIV-infected (and whose infants are HIV uninfected or of
unknown HIV status) should exclusively breastfeed their infants for the first six months of
life, introducing appropriate complementary foods thereafter, and continue breastfeeding
for the first 12 months of life. Breastfeeding should then only stop once a nutritionally
adequate and safe diet without breast milk can be provided.” (p.31).
Figure 14: Verbatim text from the WHO 2010 policy text describing the recommended length of
breastfeeding for HIV-positive mothers.
Another significant change was the inclusion of the level of quality of evidence (e.g. high
or very low) and the strength of recommendation (e.g. strong and weak). Citations of research
were included in the WHO publications on HIV and infant feeding starting in 1998, but this
publication was the first time the quality of evidence, strength of evidence, and extensive
remarks about recommendations were included in the WHO document.
Importance. The principles and recommendations in this document were a continuation
of the greater inclusion of evidence. Importantly, the level of recommendation and quality of
evidence were included for the first time. This improves stakeholders’ evaluation of the
recommendations and provides more information for the decision-making process. The inclusion
of ARVs for breastfeeding mothers and infants was a significant and long-awaited change in
recommendations. Lastly, there was a paradigm shift in the guidance on counseling HIV-positive
women and the feeding options for their infant. Although individual rights were emphasized,
national authorities were encouraged to promote and support a single recommendation as a
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“starting place” for counseling mothers with HIV. This was a significant shift from the previous
recommendations for individual counseling based on individual circumstances.
2012: WHO guidelines on HIV and infant feeding 2010 - an updated framework for
priority action.

The last major update in WHO policy 2012 and provides simpler guidance by specifying
two distinct paths for avoiding maternal-child HIV transmission via breastfeeding. Citing
estimates by the Joint United Nations Program on HIV/AIDS (UNAIDS), exclusive
breastfeeding with the addition of ARVs for the mother or the infant would decrease the risk of
transmission of HIV to about 2% for six months of exclusive breastfeeding and a risk of 4% for
12 months (WHO, 2012, p.3). The policy states that without ARV treatment, between 14 and 1717% of breastfed infants of HIV-positive mothers would have HIV by 18 months of age (WHO,
2012, p. 3).
The WHO (2012) explicitly stated that health authorities should endorse one of two
options when counseling new mothers with HIV: 1) breastfeeding while receiving ARVs (to the
mother or infant) or 2) avoidance of breastfeeding entirely (see Figure 15). The WHO advised
governments to include relevant stakeholders and the guidelines included “priority actions for
governments” (WHO, 2012, p.5). There are specific “actions required” listed in their “priority of
government action” sections (WHO, 2012, p. 5-7), including developing evidence-based national
policies and communication strategies to promote the infant feeding practice in their policy. The
roles of the United Nations Agencies are also illuminated along with challenges.

HIV AND BREASTFEEDING IN GLOBAL POLICY

35

“The operational objectives of this Strategy include: ensuring that exclusive breastfeeding for six
months is protected, promoted and supported, with continued breastfeeding up to two years or
beyond; promoting timely, adequate, sage and appropriate complementary feeding; and
providing guidance on feeding infants and young children in exceptionally difficult
circumstances, including for infants of HIV-positive women” (p.1).
“National health authorities are encourage to recommend one infant feeding practice for HIVpositive mothers to be promoted and supported by maternal, newborn, and child health
services…
WHO recommends that woman who breastfeed and receive ARVs (or whose infants are receiving
ARVs) should exclusively breastfeed for 6 months and continue breastfeeding until 12 months of
age and only then consider stopping…
The way in which national authorities implement these recommendations should depend on a
careful assessment taking into account major factors including HIV prevalence, background
infant and child mortality rates, current infant and young child feeding practices and nutritional
status of infants, availability of clean water and sanitation, socio-economic status of the
population and quality health services, including provision of interventions for PMTCT” (p. 4)
Figure 15: Verbatim text from the WHO 2012 policy explaining the new breastfeeding
recommendations for mothers with HIV.
Changes. This document is consistent with the previous 2010 Guidelines but provided
additional updated evidence. There are a number of guidelines for policy-makers and
governments, and there is a greater definition of roles for the governments and organizations
involved.
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Importance. There is an explicit shift toward addressing policy-makers, governments and
other stakeholders. There was also an emphasis on improving overall health care and the
implementation of these guidelines at the system level, and specific actionable items for
governments were given. The inclusion of challenges encourages innovative solutions and
interventions to improve the prevention of mother-to-child transmission of HIV. Lastly, there
were very clear, simple binary recommendations for counseling new mothers with HIV which
simplified the counseling process.
2014: WHO consolidated guidelines on HIV prevention, diagnosis, treatment and care
for key populations.
The most recent update of guidelines was released in 2014 (WHO, 2014a). These
consolidated guidelines recommended simultaneous treatment with three ARVs to all pregnant
and breastfeeding women (see Figure 16).
•

All pregnant and breastfeeding women living with HIV should initiate triple
antiretrovirals (ARVs), which should be maintained at least for the duration of risk of
mother-to-child transmission. Women meeting treatment eligibility criteria should
continue ART for life (CD4<500 cells/mm3) (strong recommendation, moderate quality
of evidence (WHO, 2014, p. 64).

•

For programmatic and operational reasons, particularly in generalized epidemics, all
pregnant and breastfeeding women living with HIV should initiate ART and maintain it
as lifelong treatment (option B+) (conditional recommendation, low quality of evidence)
(WHO, 2014, p. 64).

Figure 16: Verbatim text from the 2014 WHO policy concerning maternal ARV treatment.
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therapy (therapy consisting of three ARVs), as well as the recommendation for the provision of
this therapy to women for life.
Importance. This document recognized the necessity of treatment of all pregnant and
breastfeeding women for life, particularly in high prevalence settings. It continued to update the
available evidence. This 2014 policy referred to the 2012 policy for complete recommendations
and only provided an update on ARV treatment of pregnant women or infants.
Discussion
Since 1987, the WHO has attempted to provide guidelines that were both appropriate and
feasible for infant feeding in the setting of HIV. Table 1 summarizes the evolution of these
policies and their major tenants.
Table 1: Evolution of WHO Guidelines for Infant Feeding in the Setting of HIV
Year

Rate of
Transmission

Evidence

Breastfeeding (BF)
Recommendations

Counseling
Methods

ARVs

Mixed
Feeding

1987

25 to 50%
for all
offspring;
unknown for
breastfeeding (BF)
Not
mentioned

Research
starting; not
cited

Breastfeeding not
recommended

Counsel high
risk women

Do not exist

Not mentioned

Research
mentioned,
not cited

Counsel high
risk women

Do not exist

Not mentioned

25-45%,
15% from
BF

Increasing
research,
citations
included

Breastfeeding when no
other alternatives, or
where primary cause of
death is infectious
diseases
Breastfeeding with
early cessation

Counseling not
discussed
specifically

Available,
no recommendations
in setting of
breastfeeding

Not mentioned

1992

1998

HIV AND BREASTFEEDING IN GLOBAL POLICY
Table 1: Evolution of WHO Guidelines for Infant Feeding in the Setting of HIV (cont’d)

38

Year

Rate of
Transmission

Evidence

Breastfeeding (BF)
Recommendations

Counseling
Methods

ARVs

Mixed
Feeding

2001

10-20% risk
from BF

More
research,
citations
included

Cessation
recommended as soon
as AFASS

ARVs
mentioned,
being
investigated
in BF

Mixed feeding
cited as
increasing risk
for first time,
discouraged

2004

5-20% risk
from BF

More
research,
citations
included

Exclusive bf for 6
months

Counsel general
public, also
counsel HIVpositive women
with all options,
choice
emphasized
Counsel with all
choices

Mixed feeding
cited as
increasing risk,
discouraged

2007

5-20%, 1%
per month
from BF

More
research,
citations
included

Exclusive bf for 6
months

Counsel with
one primary
recommendation

2010

5-20%, 1%
per month
from BF

Exclusive bf for 6
months, continue for
minimum of 12 months
with ARVs to mother or
infant

Counsel with
one primary
recommendation

2014

Not
mentioned

More
research,
citations
included,
grading of
evidence
included
More
research,
citations
included

No recommendation for
duration of
breastfeeding,
reference to prior
guidelines

General
recommendations for care
and adherence
support

ARVs
recommend
ed as
prophylaxis,
no recommendations
for BF
ARVs
recommend
ed for
prophylaxis,
no recommendations
for BF
ARVs
recommended for
prevention
of transmission while
BF
Recommen
dation for
triple ARVs
for at least
the duration of
breastfeeding

Mixed feeding
cited as
increasing risk,
discouraged
Mixed feeding
cited as
increasing risk,
discouraged
Not mentioned,
reference to
prior
guidelines

From the first to the most recent policy, the WHO has stated clear support for “protecting
and promoting breastfeeding”. This was largely due to the excellent work of breastfeeding
experts, advocates and researchers that made documents like the 1981 International Code
possible.
Over time there was an increase in the evidence-base for specific recommendations.
More research was progressively included, with the most recent policy being the most evidence-
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based. There was also an increasing evaluation of current studies, confounding factors, and areas
highlighted for further research. Citations and references began to be included in 1998,
permitting independent evaluation of the evidence used for decision-making. It is notable that in
2010, with the inclusion of grading of evidence and the strength of a recommendation, there are
still “strong recommendations” with “low evidence.” Evidence has increased dramatically since
the start of the HIV epidemic, but there are still areas for ongoing research as long term ARV
treatment becomes the norm and HIV becomes a chronic condition.
Global practices were also given increasing attention over time. This acknowledged the
role of cultural norms and allowed a more realistic situational evaluation prior to planning
interventions. Non-exclusive breastfeeding was reported in the research to be common in certain
areas, and this practice adds a challenge to the promotion of exclusive breastfeeding. The
acceptability of infant feeding options began to be included in 2000, but an explicit and clear
discussion was not included until 2007.
One important further consideration is the shift toward the promotion of a single
recommendation for infant feeding in the setting of HIV after 2010. This recommendation was

provided based on the assumption that women would prefer to be given specific guidance instead
of a presentation of all options without indication of expert endorsement. The presentation of the
standard with a discussion of how the standard may or may not fit an individual mother’s
situation is imperative to ensure the mother’s informed consent. It may aid in decision-making to
be given specific guidance on what has been decided to be the best option; however,
recommendations are not one size-fits-all, and women should be provided with the options and
their risks/benefits.
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Furthermore, it becomes evident through reading these policies that there is a need for all
terms to be defined. For example, in the 1998 policy, breastfeeding was to be discontinued when
“adequate” replacement feeding became available. There was no definition of adequate. This is

also true for the AFASS criteria. The creation of those criteria illuminated some of the necessary
considerations for infant feeding, but it was another six years before the criteria were described
in detail. Definitions and descriptions of terminology are vital to guidelines and their successful
implantation.
Importantly, there was a fifteen-year delay between the introduction of ARV therapy and
policies for their use in the setting of HIV and breastfeeding. The policies following ARV
introduction stated a lack of sufficient scientific evidence in order to create such a policy. It is
unclear from these documents why there was such an extended delay in policy. An improved
understanding of the delay could help future life-saving protocols be better prioritized and
disseminated on a global scale.
WHO policies are an important component of international health care, and changes to
these policies alter practices and national policies. It is important to note that these changes do
not occur in a vacuum, and previous experience and knowledge of health care workers and the
people affected may create some resistance to implementation of new recommendations
(Desclaux, 2012). Women with HIV may have several children, and the recommendations may
change over the course of her reproductive life (Desclaux, 2012). It is imperative that this
confusion is minimized. Global policies may be difficult to implement in places with insufficient
health care infrastructure, particularly at the margins of a population.
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There are several limitations in this document. Due to its limited scope, there was no indepth discussion of the International Code of Marketing of Breast Milk Substitutes nor the infant
formula industry’s response/impact on HIV and replacement feeding. There was also no
discussion of the impact of HIV on worldwide donor milk banking. This document contains all
the WHO documents on HIV and infant feeding that were found, but there may be others that
were not found and therefore omitted.
Conclusions and Recommendations
The balancing of preventing HIV transmission through breastfeeding and the importance
of breastfeeding has been a challenge for more than 30 years. It is irrefutable that breastfeeding
should continue to be promoted, supported and protected as the optimal feeding method for most
infants while also preventing the transmission of HIV from mother-to-child. There is no single
strategy that is applicable everywhere, varying based on the population, resources, and the
environment. Policies should include as much evidence as possible, as many stakeholders as
possible, and an attempt to close the gap between policy and practice. Policies must also
recognize the previous knowledge and experience of mothers and health care workers impacts
the implementation of policy (see Figure 16).
This is not simply a matter of a structural insufficiency of human resources in African health
services; rather, this expresses the fact that heath policies still to often consider persons targeted
by such programs to be ‘empty receptacles’ who will adopt medical recommendations on the
spot without interpreting them, as if they had no experience, no other source of information of
framework for interpretation, and no memory (Desclaux, 2013, p. 42).
Figure 16: Text verbatim from Desclaux 2013 on the gap between practice and policy.
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The policies evaluated demonstrate the evolution in knowledge and recommendations for
infant feeding practices in the setting of HIV. There is a continued challenge for policymakers,
women, and health care workers to interpret the incomplete information to provide the best
recommendations for infant feeding in the setting of HIV. The most recent updates (WHO 2012,
WHO 2014) suggest that policy may be stabilizing considering the lack of significant changes
from 2012 to 2014 beyond the ARV protocol. However, this evaluation of previous policies has
demonstrated the need for continually clarifying terminology, descriptive criteria and practices,
and increasing the evidence-base in order to create effective and accurate recommendations in
the future.
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Appendix: List of Competencies Met in CE
Tier 1 Core Public Health Competencies
Domain #1: Analytic/Assessment Skills
Identifies quantitative and qualitative data and information (e.g., vital statistics, electronic health records,
transportation patterns, unemployment rates, community input, health equity impact assessments) that can be
used for assessing the health of a community
Applies ethical principles in accessing, collecting, analyzing, using, maintaining, and disseminating data and
information
Uses information technology in accessing, collecting, analyzing, using, maintaining, and disseminating data
and information
Selects valid and reliable data
Selects comparable data (e.g., data being age-adjusted to the same year, data variables across datasets
having similar definitions)
Identifies gaps in data
Describes public health applications of quantitative and qualitative data
Uses quantitative and qualitative data
Contributes to assessments of community health status and factors influencing health in a community (e.g.,
quality, availability, accessibility, and use of health services; access to affordable housing)
Describes how evidence (e.g., data, findings reported in peer-reviewed literature) is used in decision making
Domain #2: Policy Development/Program Planning Skills
Contributes to development of program goals and objectives
Describes organizational strategic plan (e.g., includes measurable objectives and targets; relationship to
community health improvement plan, workforce development plan, quality improvement plan, and other plans)
Identifies current trends (e.g., health, fiscal, social, political, environmental) affecting the health of a community
Describes implications of policies, programs, and services
Explains the importance of evaluations for improving policies, programs, and services
Describes how public health informatics is used in developing, implementing, evaluating, and improving
policies, programs, and services (e.g., integrated data systems, electronic reporting, knowledge management
systems, geographic information systems)
Domain #3: Communication Skills
Communicates in writing and orally with linguistic and cultural proficiency (e.g., using age-appropriate
materials, incorporating images)
Conveys data and information to professionals and the public using a variety of approaches (e.g., reports,
presentations, email, letters)
Describes the roles of governmental public health, health care, and other partners in improving the health of a
community
Domain #4: Cultural Competency Skills
Describes the concept of diversity as it applies to individuals and populations (e.g., language, culture, values,
socioeconomic status, geography, education, race, gender, age, ethnicity, sexual orientation, profession,
religious affiliation, mental and physical abilities, historical experiences)
Describes the diversity of individuals and populations in a community
Describes the ways diversity may influence policies, programs, services, and the health of a community
Recognizes the contribution of diverse perspectives in developing, implementing, and evaluating policies,
programs, and services that affect the health of a community
Addresses the diversity of individuals and populations when implementing policies, programs, and services
that affect the health of a community
Describes the effects of policies, programs, and services on different populations in a community
Describes the value of a diverse public health workforce
Domain #5: Community Dimensions of Practice Skills
Recognizes relationships that are affecting health in a community (e.g., relationships among health
departments, hospitals, community health centers, primary care providers, schools, community-based
organizations, and other types of organizations)
Provides input for developing, implementing, evaluating, and improving policies, programs, and services
Informs the public about policies, programs, and resources that improve health in a community
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Domain #6:Public Health Sciences Skills
Identifies prominent events in the history of public health (e.g., smallpox eradication, development of
vaccinations, infectious disease control, safe drinking water, emphasis on hygiene and hand washing, access
to health care for people with disabilities)
Retrieves evidence (e.g., research findings, case reports, community surveys) from print and electronic
sources (e.g., PubMed, Journal of Public Health Management and Practice, Morbidity and Mortality Weekly
Report, The World Health Report) to support decision making
Recognizes limitations of evidence (e.g., validity, reliability, sample size, bias, generalizability)
Describes evidence used in developing, implementing, evaluating, and improving policies, programs, and
services
Describes the laws, regulations, policies, and procedures for the ethical conduct of research (e.g., patient
confidentiality, protection of human subjects, Americans with Disabilities Act)
Contributes to the public health evidence base (e.g., participating in Public Health Practice-Based Research
Networks, community-based participatory research, and academic health departments; authoring articles;
making data available to researchers)
Suggests partnerships that may increase use of evidence in public health practice (e.g., between practice and
academic organizations, with health sciences libraries)
Domain #7: Financial Planning and Management Skills
Describes the structures, functions, and authorizations of governmental public health programs and
organizations
Describes government agencies with authority to impact the health of a community
Domain #8: Leadership and Systems Thinking Skills
Describes public health as part of a larger inter-related system of organizations that influence the health of
populations at local, national, and global levels
Describes the ways public health, health care, and other organizations can work together or individually to
impact the health of a community
Contributes to development of a vision for a healthy community (e.g., emphasis on prevention, health equity
for all, excellence and innovation)
Identifies internal and external facilitators and barriers that may affect the delivery of the 10 Essential Public
Health Services (e.g., using root cause analysis and other quality improvement methods and tools, problem
solving)
Describes the impact of changes (e.g., social, political, economic, scientific) on organizational practices

Global Health:

Concentration Specific Competencies

Exhibit interpersonal skills that demonstrate willingness to collaborate, trust building abilities, and
respect for other perspectives
Identify and respond with integrity and professionalism to ethical issues in diverse economic, political,
and cultural contexts
Apply the health equity and social justice framework for the analysis of strategies to address health
disparities across different populations
Conduct evaluation and research related to global health
Enhance socio-cultural and political awareness
Apply systems thinking to analyze a diverse range of complex and interrelated factors shaping health
at local, national, and international levels
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